A detailed history of Nuveen, LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 208,759 shares of IDYA stock, worth $6.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
208,759
Previous 217,320 3.94%
Holding current value
$6.71 Million
Previous $4.57 Million 24.34%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$21.12 - $27.21 $180,808 - $232,944
-8,561 Reduced 3.94%
208,759 $5.68 Million
Q2 2025

Aug 12, 2025

SELL
$14.5 - $22.63 $1.01 Million - $1.58 Million
-69,994 Reduced 24.36%
217,320 $4.57 Million
Q1 2025

May 12, 2025

BUY
$16.38 - $26.0 $4.71 Million - $7.47 Million
287,314 New
287,314 $4.71 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.54B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Nuveen, LLC Portfolio

Follow Nuveen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.